| Visualizing extravasation dynamics of metastatic tumor cells K Stoletov, H Kato, E Zardouzian, J Kelber, J Yang, S Shattil, R Klemke Journal of cell science 123 (13), 2332-2341, 2010 | 384 | 2010 |
| GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor β signaling and enhance cell growth G Shani, WH Fischer, NJ Justice, JA Kelber, W Vale, PC Gray Molecular and cellular biology 28 (2), 666-677, 2008 | 216 | 2008 |
| Role of connexins in metastatic breast cancer and melanoma brain colonization K Stoletov, J Strnadel, E Zardouzian, M Momiyama, FD Park, JA Kelber, ... Journal of cell science 126 (4), 904-913, 2013 | 211 | 2013 |
| Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways JA Kelber, AD Panopoulos, G Shani, EC Booker, JC Belmonte, WW Vale, ... Oncogene 28 (24), 2324-2336, 2009 | 205 | 2009 |
| Tumor Microenvironment Heterogeneity: Challenges and Opportunities F Runa, S Hamalian, K Meade, P Shisgal, PC Gray, JA Kelber Current Molecular Biology Reports, 1-12, 2017 | 142 | 2017 |
| Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness P Soman, JA Kelber, JW Lee, TN Wright, KS Vecchio, RL Klemke, S Chen Biomaterials 33 (29), 7064-7070, 2012 | 134 | 2012 |
| KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer JA Kelber, T Reno, S Kaushal, C Metildi, T Wright, K Stoletov, JM Weems, ... Cancer research 72 (10), 2554-2564, 2012 | 127 | 2012 |
| Cripto binds transforming growth factor β (TGF-β) and inhibits TGF-β signaling PC Gray, G Shani, K Aung, J Kelber, W Vale Molecular and cellular biology 26 (24), 9268-9278, 2006 | 122 | 2006 |
| Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression Y Wang, JA Kelber, HST Cao, GT Cantin, R Lin, W Wang, S Kaushal, ... Proceedings of the National Academy of Sciences 107 (24), 10920-10925, 2010 | 121 | 2010 |
| A hypusine–eIF5A–PEAK1 switch regulates the pathogenesis of pancreatic cancer K Fujimura, T Wright, J Strnadel, S Kaushal, C Metildi, AM Lowy, M Bouvet, ... Cancer research 74 (22), 6671-6681, 2014 | 100 | 2014 |
| Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal JA Kelber, G Shani, EC Booker, WW Vale, PC Gray Journal of Biological Chemistry 283 (8), 4490-4500, 2008 | 88 | 2008 |
| CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo BT Spike, JA Kelber, E Booker, M Kalathur, R Rodewald, J Lipianskaya, ... Stem cell reports 2 (4), 427-439, 2014 | 76 | 2014 |
| eIF5A-PEAK1 signaling regulates YAP1/TAZ protein expression and pancreatic cancer cell growth J Strnadel, S Choi, K Fujimura, H Wang, W Zhang, M Wyse, T Wright, ... Cancer research 77 (8), 1997-2007, 2017 | 66 | 2017 |
| ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer JAK Armen Gharibi, Sa La Kim, Justin Molnar, Daniel Brambilla, Yvess Adamian ... Scientific Reports, 2017 | 65 | 2017 |
| Cellular and Molecular Aspects of Pancreatic cancer A Gharibi, Y Adamian, J Kelber Acta Histochemica, 2016 | 55 | 2016 |
| PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer M Agajanian, A Campeau, M Hoover, A Hou, D Brambilla, SL Kim, ... PLoS ONE 10 (8), 2015 | 51 | 2015 |
| Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer M Agajanian, F Runa, JA Kelber BBRC, 2015 | 46 | 2015 |
| CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer MKJ E Zoni, L Chen, S Karkampouna, Z Granchi, E Verhoef, F La Manna, J ... Oncogene, 2017 | 45 | 2017 |
| Designer TGFβ superfamily ligands with diversified functionality GP Allendorph, JD Read, Y Kawakami, JA Kelber, MJ Isaacs, S Choe PLoS One 6 (11), e26402, 2011 | 42 | 2011 |
| Cell surface GRP78 promotes stemness in normal and neoplastic cells C Conner, TW Lager, IH Guldner, MZ Wu, Y Hishida, T Hishida, S Ruiz, ... Scientific reports 10 (1), 3474, 2020 | 40 | 2020 |
Peter C GrayThe Salk InstituteVerified email at salk.edu
